Nurse Family Partnership program for first-time mothers in Norway
The Mother in Norway Study - A Randomised Trial of Nurse-Family Partnership (NFP)
This study tests if the Nurse Family Partnership program can help first-time mothers in Norway reduce child abuse and improve their family's well-being compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 700 (estimated) |
| Ages | 16 Years and up |
| Sex | Female |
| Sponsor | Oslo Metropolitan University Academic / other |
| Locations | 5 sites (Bergen, Bergen and 4 other locations) |
| Trial ID | NCT05895604 on ClinicalTrials.gov |
What this trial studies
This study evaluates the Nurse Family Partnership (NFP) program in Norway, aimed at reducing child abuse and social inequality among first-time mothers. It involves a randomized controlled trial with 700 participants, where half will receive NFP services and the other half will receive standard care. The primary focus is on assessing violence towards mothers and their children through questionnaires and observation tests at various stages of the child's development. Additionally, the study will analyze health-related outcomes and conduct cost-effectiveness evaluations to improve service delivery.
Who should consider this trial
Good fit: Ideal candidates for this study are first-time mothers who are currently pregnant and less than 28 weeks gestation.
Not a fit: Patients who have had previous live births or are not currently pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce instances of violence against mothers and their children, improving overall maternal and child health.
How similar studies have performed: Previous studies of the Nurse Family Partnership program in other regions have shown positive outcomes, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Female; No previous live births; Currently pregnant; Gestation period less than 28 weeks (i.e., less than or equal to 27 weeks, 6 days) at time of recruitment; Live within an area serviced by a NFP Implementing Agency; Not currently enrolled in the study; professionals are concerned about the pregnancy / impending parenthood Exclusion Criteria: Women who have had a previous live birth; Women who are not currently pregnant; Women who are past their 28th week of gestation (i.e., greater than or equal to 28 weeks, 0 days) at time of recruitment; Women who live outside of an area serviced by a NFP Implementing Agency; Women who are currently enrolled in the study; professionals are not concerned about the pregnancy / impending parenthood
Where this trial is running
Bergen, Bergen and 4 other locations
- Region Vestland — Bergen, Bergen, Norway (Recruiting)
- Region Agder — Kristiansand, Kristiansand, Norway (Recruiting)
- Region Rogaland — Sandnes, Sandnes, Norway (Recruiting)
- Region Trøndelag — Trondheim, Trondheim, Norway (Recruiting)
- Region Oslo — Oslo, Norway (Recruiting)
Study contacts
- Principal investigator: Anne Grete Tøge, phd — Oslo Metropolitan University
- Study coordinator: Anne Grete Tøge, phd
- Email: Anne-Grete.Toge@oslomet.no
- Phone: +47 67 23 81 58
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.